Veru (VERU) Analysts See $-0.04 EPS; LOT78 (LOTE) Sellers Decreased By 16.25% Their Shorts

November 15, 2017 - By Richard Conner

Analysts expect Veru Inc (NASDAQ:VERU) to report $-0.04 EPS on December, 11.They anticipate $0.02 EPS change or 33.33% from last quarter’s $-0.06 EPS. After having $-0.03 EPS previously, Veru Inc’s analysts see 33.33% EPS growth. The stock decreased 9.02% or $0.11 on November 14, reaching $1.11. About shares traded. Veru Inc (NASDAQ:VERU) has 0.00% since November 15, 2016 and is . It has underperformed by 16.70% the S&P500.

LOT78 INCORPORATED (OTCMKTS:LOTE) had a decrease of 16.25% in short interest. LOTE’s SI was 20,100 shares in November as released by FINRA. Its down 16.25% from 24,000 shares previously. With 348,500 avg volume, 0 days are for LOT78 INCORPORATED (OTCMKTS:LOTE)’s short sellers to cover LOTE’s short positions. The stock decreased 1.39% or $0.0008 on November 14, reaching $0.0547. About shares traded. Lot78 Inc (OTCMKTS:LOTE) has 0.00% since November 15, 2016 and is . It has underperformed by 16.70% the S&P500.

Lot78, Inc. is a business development company. The company has market cap of $8.94 million. The Company’s principal service involves the facilitation of growth of those companies it invests in. It currently has negative earnings. The Firm is targeting approximately 20% holding in an electric vehicle charging station company.

Veru Inc., formerly The Female Health Company, is a therapeutics firm focused on developing and commercializing pharmaceuticals and devices in men’s and women’s health and oncology. The company has market cap of $59.06 million. The Firm is engaged in the development, manufacture and marketing of consumer healthcare products. It currently has negative earnings. The Firm has three divisions: Pharmaceutical and Devices, Consumer Health Products and Public Sector.

Receive News & Ratings Via Email - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings with our FREE daily email newsletter.

By1 Richard Conner




Automatic Stock Updates

Enter your email address below to get the latest news and analysts' ratings for your stocks with our free daily email newsletter: